AG
MDCO

Artal Group’s Medicines Co MDCO Stock Holding History

Artal Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,400,000
Closed -$70M – 115
2019
Q3 		$70M Buy
1,400,000
+400,000
+40% +$16M 2.81% 9
2019
Q2 		$36.5M Buy
1,000,000
+300,000
+43% +$9.79M 1.48% 15
2019
Q1 		$19.6M Buy
700,000
+300,000
+75% +$7.07M 0.8% 29
2018
Q4 		$7.66M Hold
400,000
– – 0.28% 53
2018
Q3 		$12M Hold
400,000
– – 0.31% 46
2018
Q2 		$14.7M Buy
400,000
+200,000
+100% +$6.5M 0.31% 34
2018
Q1 		$6.59M Hold
200,000
– – 0.08% 60
2017
Q4 		$5.47M Sell
200,000
-100,000
-33% -$3.08M 0.08% 67
2017
Q3 		$11.1M Sell
300,000
-50,000
-14% -$1.84M 0.19% 38
2017
Q2 		$13.3M Buy
350,000
+250,000
+250% +$11.1M 0.23% 31
2017
Q1 		$4.89M Buy
100,000
+50,000
+100% +$2.28M 0.11% 60
2016
Q4 		$1.7M Buy
+50,000
New +$1.77M 0.04% 80

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Artal Group's MDCO Position: Q4 2019 in Review

Artal Group sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 1,400,000 shares — an estimated $70M sold.

Artal Group first reported a position in MDCO in Q4 2016 and held it in 12 quarters. The position peaked at $70M in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Artal Group reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Artal Group sold 1,400,000 Medicines Co shares in Q4 2019, an estimated $70M.
  • Artal Group first reported a position in Medicines Co in Q4 2016 and held it in 12 quarters.
  • Artal Group's Medicines Co position peaked at $70M in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Artal Group's 13F filing for Q4 2019, filed 13 Feb 2020.